glp-1 taste in mouth Glucagon-Like Peptide 1 and What is 'Ozempic tongue?' Connecticut

doi: 10.1016/j.lwt.2023.115405 56

Innovations in pharmaceutical formulations have substantially improved therapeutic peptide administration by providing the following advantages: long-acting delivery, precise dose administration, retention of biological activity, and improvement of patient compliance

Research suggests GHRP-2 may exert its activity by binding to the ghrelin receptor (GHS-R1a), potentially influencing hormone release and appetite-related signaling

Gastroparesis, sometimes called stomach paralysis, involves severely delayed gastric emptying that goes beyond the normal slowing these drugs produce

This may explain the comparatively high discontinuation rate of 10.6% for those on the highest dose of orforglipron, a higher figure than the 7% observed for the investigational oral semaglutide